158 related articles for article (PubMed ID: 32445880)
1. White matter hyperintensities are associated with subthreshold amyloid accumulation.
Moscoso A; Rey-Bretal D; Silva-Rodríguez J; Aldrey JM; Cortés J; Pías-Peleteiro J; Ruibal Á; Aguiar P;
Neuroimage; 2020 Sep; 218():116944. PubMed ID: 32445880
[TBL] [Abstract][Full Text] [Related]
2. Association between brain amyloid deposition and longitudinal changes of white matter hyperintensities.
Cha WJ; Yi D; Ahn H; Byun MS; Chang YY; Choi JM; Kim K; Choi H; Jung G; Kang KM; Sohn CH; Lee YS; Kim YK; Lee DY
Alzheimers Res Ther; 2024 Mar; 16(1):50. PubMed ID: 38454444
[TBL] [Abstract][Full Text] [Related]
3. White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS).
Eloyan A; Thangarajah M; An N; Borowski BJ; Reddy AL; Aisen P; Dage JL; Foroud T; Ghetti B; Griffin P; Hammers D; Iaccarino L; Jack CR; Kirby K; Kramer J; Koeppe R; Kukull WA; La Joie R; Mundada NS; Murray ME; Nudelman K; Rumbaugh M; Soleimani-Meigooni DN; Toga A; Touroutoglou A; Atri A; Day GS; Duara R; Graff-Radford NR; Honig LS; Jones DT; Masdeu J; Mendez MF; Musiek E; Onyike CU; Rogalski E; Salloway S; Sha S; Turner RS; Wingo TS; Wolk DA; Womack K; Beckett L; Gao S; Carrillo MC; Rabinovici G; Apostolova LG; Dickerson B; Vemuri P;
Alzheimers Dement; 2023 Nov; 19 Suppl 9(Suppl 9):S89-S97. PubMed ID: 37491599
[TBL] [Abstract][Full Text] [Related]
4. Amyloid burden accelerates white matter degradation in cognitively normal elderly individuals.
Vipin A; Ng KK; Ji F; Shim HY; Lim JKW; Pasternak O; Zhou JH;
Hum Brain Mapp; 2019 May; 40(7):2065-2075. PubMed ID: 30604903
[TBL] [Abstract][Full Text] [Related]
5. Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns.
Pålhaugen L; Sudre CH; Tecelao S; Nakling A; Almdahl IS; Kalheim LF; Cardoso MJ; Johnsen SH; Rongve A; Aarsland D; Bjørnerud A; Selnes P; Fladby T
J Cereb Blood Flow Metab; 2021 May; 41(5):1162-1174. PubMed ID: 32955960
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal Association between White Matter Hyperintensities and White Matter Beta-Amyloid Deposition in Cognitively Unimpaired Elderly.
Wang ML; Yu MM; Li WB; Li YH
Curr Alzheimer Res; 2021; 18(1):8-13. PubMed ID: 33761854
[TBL] [Abstract][Full Text] [Related]
7. Reduced [
Moscoso A; Grothe MJ; Schöll M;
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2283-2294. PubMed ID: 33475761
[TBL] [Abstract][Full Text] [Related]
8. Cerebral amyloid is associated with greater white-matter hyperintensity accrual in cognitively normal older adults.
Scott JA; Braskie MN; Tosun D; Maillard P; Thompson PM; Weiner M; DeCarli C; Carmichael OT;
Neurobiol Aging; 2016 Dec; 48():48-52. PubMed ID: 27639120
[TBL] [Abstract][Full Text] [Related]
9. Reference region selection and the association between the rate of amyloid accumulation over time and the baseline amyloid burden.
Blautzik J; Brendel M; Sauerbeck J; Kotz S; Scheiwein F; Bartenstein P; Seibyl J; Rominger A;
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1364-1374. PubMed ID: 28326436
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal Relationships of White Matter Hyperintensities and Alzheimer Disease Biomarkers Across the Adult Life Span.
Luo J; Ma Y; Agboola FJ; Grant E; Morris JC; McDade E; Fagan AM; Benzinger TLS; Hassenstab J; Bateman RJ; Perrin RJ; Gordon BA; Goyal M; Strain JF; Yakushev I; Day GS; Xiong C;
Neurology; 2023 Jul; 101(2):e164-e177. PubMed ID: 37202169
[TBL] [Abstract][Full Text] [Related]
11. White matter hyperintensities are a prominent feature of autosomal dominant Alzheimer's disease that emerge prior to dementia.
Schoemaker D; Zanon Zotin MC; Chen K; Igwe KC; Vila-Castelar C; Martinez J; Baena A; Fox-Fuller JT; Lopera F; Reiman EM; Brickman AM; Quiroz YT
Alzheimers Res Ther; 2022 Jun; 14(1):89. PubMed ID: 35768838
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of PiB visual interpretation with CSF Aβ and longitudinal SUVR in J-ADNI study.
Okada Y; Kato T; Iwata K; Kimura Y; Nakamura A; Hattori H; Toyama H; Ishii K; Ishii K; Senda M; Ito K; Iwatsubo T;
Ann Nucl Med; 2020 Feb; 34(2):108-118. PubMed ID: 31749127
[TBL] [Abstract][Full Text] [Related]
13. Influence of White Matter Hyperintensities on Baseline and Longitudinal Amyloid-β in Cognitively Normal Individuals.
Wong FCC; Saffari SE; Yatawara C; Ng KP; Kandiah N;
J Alzheimers Dis; 2021; 84(1):91-101. PubMed ID: 34511497
[TBL] [Abstract][Full Text] [Related]
14. Patterns of white matter hyperintensities associated with cognition in middle-aged cognitively healthy individuals.
Brugulat-Serrat A; Salvadó G; Sudre CH; Grau-Rivera O; Suárez-Calvet M; Falcon C; Sánchez-Benavides G; Gramunt N; Fauria K; Cardoso MJ; Barkhof F; Molinuevo JL; Gispert JD;
Brain Imaging Behav; 2020 Oct; 14(5):2012-2023. PubMed ID: 31278650
[TBL] [Abstract][Full Text] [Related]
15. Association of Regional White Matter Hyperintensities With Longitudinal Alzheimer-Like Pattern of Neurodegeneration in Older Adults.
Rizvi B; Lao PJ; Chesebro AG; Dworkin JD; Amarante E; Beato JM; Gutierrez J; Zahodne LB; Schupf N; Manly JJ; Mayeux R; Brickman AM
JAMA Netw Open; 2021 Oct; 4(10):e2125166. PubMed ID: 34609497
[TBL] [Abstract][Full Text] [Related]
16. Association Between Late-Life Neuropsychiatric Symptoms and Cognitive Decline in Relation to White Matter Hyperintensities and Amyloid Burden.
Chan CK; Pettigrew C; Soldan A; Zhu Y; Wang MC; Albert M; Rosenberg PB;
J Alzheimers Dis; 2022; 86(3):1415-1426. PubMed ID: 35213370
[TBL] [Abstract][Full Text] [Related]
17. Topographic patterns of white matter hyperintensities are associated with multimodal neuroimaging biomarkers of Alzheimer's disease.
Gaubert M; Lange C; Garnier-Crussard A; Köbe T; Bougacha S; Gonneaud J; de Flores R; Tomadesso C; Mézenge F; Landeau B; de la Sayette V; Chételat G; Wirth M
Alzheimers Res Ther; 2021 Jan; 13(1):29. PubMed ID: 33461618
[TBL] [Abstract][Full Text] [Related]
18. Improved power for characterizing longitudinal amyloid-β PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region.
Chen K; Roontiva A; Thiyyagura P; Lee W; Liu X; Ayutyanont N; Protas H; Luo JL; Bauer R; Reschke C; Bandy D; Koeppe RA; Fleisher AS; Caselli RJ; Landau S; Jagust WJ; Weiner MW; Reiman EM;
J Nucl Med; 2015 Apr; 56(4):560-6. PubMed ID: 25745091
[TBL] [Abstract][Full Text] [Related]
19. Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease.
Shirzadi Z; Schultz SA; Yau WW; Joseph-Mathurin N; Fitzpatrick CD; Levin R; Kantarci K; Preboske GM; Jack CR; Farlow MR; Hassenstab J; Jucker M; Morris JC; Xiong C; Karch CM; Levey AI; Gordon BA; Schofield PR; Salloway SP; Perrin RJ; McDade E; Levin J; Cruchaga C; Allegri RF; Fox NC; Goate A; Day GS; Koeppe R; Chui HC; Berman S; Mori H; Sanchez-Valle R; Lee JH; Rosa-Neto P; Ruthirakuhan M; Wu CY; Swardfager W; Benzinger TLS; Sohrabi HR; Martins RN; Bateman RJ; Johnson KA; Sperling RA; Greenberg SM; Schultz AP; Chhatwal JP;
JAMA Neurol; 2023 Dec; 80(12):1353-1363. PubMed ID: 37843849
[TBL] [Abstract][Full Text] [Related]
20. White matter hyperintensities influence distal cortical β-amyloid accumulation in default mode network pathways.
Ali DG; Bahrani AA; El Khouli RH; Gold BT; Jiang Y; Zachariou V; Wilcock DM; Jicha GA
Brain Behav; 2023 Oct; 13(10):e3209. PubMed ID: 37534614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]